Mutual fund · AMFI 152084
HDFC Pharma and Healthcare Fund
NAV ₹22.57 · 18 Nov 2026
HDFC Pharma and Healthcare Fund is a sectoral/ thematic mutual fund run by . Its NAV was ₹22.57 on 18 Nov 2026, up 29.5% over one year and 28.9% a year over three years. The direct plan's total expense ratio was 1.08% in the latest AMFI data. The top 10 holdings made up 51.7% of the portfolio in October 2026.
Returns from NAV
One year and shorter are absolute; three and five years are annualised. Based on NAV, so dividend payouts are not added back. Past performance does not guarantee future results.
Risk · last 3.0 years
How bumpy the ride has been
Worked out from weekly NAVs. The largest fall ran from 02 Jan 2025 to 28 Feb 2025. Sharpe and Sortino use a fixed 6.5% a year risk-free rate for comparison. Past figures are not a guide to future returns.
What the fund charges
From AMFI's expense ratio data, updated 19 Nov 2026. The regular plan charges more; see the fund's factsheet.
Portfolio · October 2026
Top holdings (38 in total)
| Company | % of fund | vs last month |
|---|---|---|
| Divis Laboratories Ltd. | new | |
| Sun Pharmaceutical Industries Ltd. | new | |
| Dr Reddys Laboratories Ltd. | new | |
| Apollo Hospitals Enterprise Ltd. | new | |
| Alkem Laboratories Ltd. | new | |
| Cipla Ltd. | new | |
| Acutaas Chemicals Limited | new | |
| Max Healthcare Institute Limited | new | |
| Aster DM Quality Care Limited | new | |
| Lupin Ltd. | new | |
| Torrent Pharmaceuticals Ltd. | new | |
| Neuland Laboratories Limited | new | |
| Anthem Biosciences Limited | new | |
| Shilpa Medicare Ltd | new | |
| Rubicon Research Limited | new |
The top 10 make up 51.7% of the fund. Source: the fund house's monthly portfolio disclosure.
By sector
Where the money is
Pharmaceuticals & Biotechnology70.9%
Healthcare Services24.8%
Healthcare Equipment & Supplies2.2%
Retailing0.9%
Learn more
Mutual fund guides
Your mutual funds
Review your own mutual fund portfolio
Upload or fetch your holdings and see each fund's returns, cost and overlap against benchmarks, as facts. Review my mutual funds
Questions
About HDFC Pharma and Healthcare Fund
What is the NAV of HDFC Pharma and Healthcare Fund?
The net asset value was Rs 22.57 on 18 November 2026.
What is the expense ratio of HDFC Pharma and Healthcare Fund?
The direct plan's total expense ratio was 1.08% in the latest AMFI data, about Rs 10,800 a year on Rs 10 lakh invested.
What is the one-year return of HDFC Pharma and Healthcare Fund?
The NAV changed by 29.5% over the last year; past returns do not indicate future returns.
Data source: AMFI (Association of Mutual Funds in India) for NAVs and expense ratios; portfolio holdings from the fund house's monthly disclosures.
Data: AMFI NAVs and expense ratios and the fund house's monthly portfolio disclosures. This page states facts and is not a recommendation to buy or sell. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future results.